Loading Page
Dr. Srisindu Vellanki, MD is a hepatologist in Prosper, TX specializing in hepatology (liver disease), gastroenterology (digestive system), pediatric gastroenterology and general practice. She graduated from Saint Louis University School of Medicine in 2015 and has 11 years of experience. Dr. Srisindu Vellanki, MD is affiliated with Texas Health Resources, UT Southwestern Medical Center and Children's Health Specialty Center Dallas Campus.
Dr. Srisindu Vellanki, MD graduated from Saint Louis University School of Medicine in 2015. She completed residency at Lucile Packard Children's Hospital Stanford. She has a state license in Pennsylvania.
Medical School: Saint Louis University School of Medicine (2015)
Residency: Lucile Packard Children's Hospital Stanford (2018)
Licensed In: Pennsylvania
Dr. Srisindu Vellanki, MD is associated with these hospitals and organizations:
Dr. Srisindu Vellanki, MD does not have any reviews yet, be the first to leave a review of Dr. Srisindu Vellanki, MD here: Leave a Review
These charts describe general payments received by Dr. Srisindu Vellanki, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$96
RELIZORB $96 |
|
|
$59
DUPIXENT $59 |
|
|
$46
SUCRAID $46 |
|
|
$24
GATTEX $24 |
| $225 |
Dr. Srisindu Vellanki's medical specialty is general practice, pediatric gastroenterology, and hepatology (liver disease). She speaks Spanish. Dr. Vellanki is especially interested in inflammatory bowel disease and complementary or alternative therapy. She is professionally affiliated with Texas Health Dallas and UT Southwestern Medical Center. She attended St. Louis University School of Medicine and subsequently trained at Lucile Packard Children's Hospital and Stanford Hospital & Clinics for residency. Awards and/or distinctions Dr. Vellanki has received include GI Fellowship Citizenship Award; Children s Hospital of Philadelphia; and Alpha Omega Alpha Honor Society. Her practice in Prosper, TX is open to new patients as reported by Yext.
